The complexed structure and antimicrobial activity of a non-β-lactam inhibitor of AmpC β-lactamase

Protein Science

Volumn 8, Issue 11, 1999, Pages 2330-2337

  Powers, Rachel A ^a   Blázquez, Jesús ^b   Weston, G Scott ^a,c   Morosini, María Isabel ^b   Baquero, Fernando ^b   Shoichet, Brian K ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c ARQULE INC   (United States)

Author keywords

AmpC; Antibiotic resistance; Non lactam inhibitor of lactamase; lactamase

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; BENZOTHIOPHENE; BETA LACTAMASE; CEFALOTIN; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; CITROBACTER FREUNDII; DRUG STRUCTURE; ENTEROBACTER; ESCHERICHIA COLI; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; X RAY CRYSTALLOGRAPHY;

BACTERIA (MICROORGANISMS); CITROBACTER FREUNDII; ENTEROBACTER; ESCHERICHIA COLI; NEGIBACTERIA; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0345102428     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.8.11.2330     Document Type: Article

References (42)

1. Bacon DJ, Anderson WF. 1988. A fast algorithm for rendering space-filling molecule pictures. J Mol Graph 6:219-220.
2. Baquero F, Blazquez J. 1997. Evolution of antibiotic resistance. Trends Ecol Evol 11:482-487.
3. Beesley T, Gascoyne N, Knott-Hunziker V, Petursson S, Waley SG, Jaurin B, Grundstrom T. 1983. The inhibition of class C beta-lactamases by boronic acids. Biochem J 209:229-233.
4. Bennett PM, Chopra I. 1993. Molecular basis of beta-lactamase induction in bacteria. Antimicrobial Agents Chemother 37:153-158.
5. Brünger AT. 1992. X-PLOR version 3.1: A system for X-ray crystallography and NMR. New Haven, Connecticut: Yale University Press.
6. Bulychev A, Massova I, Miyashita K, Mobashery S. 1997. Nuances of mechanisms and their implications for evolution of the versatile beta-lactamase activity: From biosynthetic enzymes to drug resistance factors. J Am Chem Soc 119:7619-7625.
7. Bush K. 1997. The evolution of beta-lactamases. Ciba Found Symp 207:152-163.
8. Bush K, Jacoby GA, Medeiros AA. 1995. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrobial Agents Chemother 39:1211-1233.
9. Casadaban MJ. 1976. Transposition and fusion of the lac genes to selected promoters in Escherichia coli using bacteriophage lambda and Mu. J Mol Biol 104:541-555.
10. Chen CC, Rahil J, Pratt RF, Herzberg O. 1993. Structure of a phosphonate-inhibited beta-lactamase. An analog of the tetrahedral transition state/ intermediate of beta-lactam hydrolysis. J Mol Biol 234:165-178.
11. Davies J. 1994. Inactivation of antibiotics and the dissemination of resistance genes. Science 264:375-382.
12. Dubus A, Ledent P, Lamotte-Brasseur J, Frere JM. 1996. The roles of residues Tyr150, Glu272, and His314 in class C beta-lactamases. Proteins 25:473-485.
13. Dubus A, Normark S, Kania M, Page MG. 1994. The role of tyrosine 150 in catalysis of beta-lactam hydrolysis by AmpC beta-lactamase from Escherichia coli investigated by site-directed mutagenesis. Biochemistry 33:8577-8586.
14. Esnouf RM. 1997. An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. J Mol Graph Model 15:132-134, 112-113.
15. Ferrin TE, Huang CC, Jarvis LE, Langridge R. 1988. The MIDAS display system. J Mol Graph 6:13-27.
16. Gonzalez Leiza M, Perez-Diaz JC, Ayala J, Casellas JM, Martinez-Beltran J, Bush K, Baquero F. 1994. Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants. Antimicrobiol Agents Chemother 38:2150-2157.
17. Hall MN, Silhavy TJ. 1979. Transcriptional regulation of Escherichia coli K-12 major outer membrane protein 1b. J Bacteriol 140:342-350.
18. Hall MN, Silhavy TJ, 1981. The ompB locus and the regulation of the major outer membrane porin proteins of Escherichia coli K12. J Mol Biol 146: 23-43.
19. Jacobs C, Frere JM, Normark S. 1997. Cytosolic intermediates for cell wall biosynthesis and degradation control inducible beta-lactam resistance in Gram-negative bacteria. Cell 88:823-832.
20. Jones TA, Zou JY, Cowan SW, Kjeldgaard. 1991. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 47:110-119.
21. Kadima TA, Weiner JH. 1997. Mechanism of suppression of piperacillin resistance in enterobacteria by tazobactam. Antimicrobial Agents Chemother 41:2177-2183.
22. Koeck JL, Arlet G, Philippon A, Basmaciogullari S, Thien HV, Buisson Y, Cavallo JD. 1997. A plasmid-mediated CMY-2 beta-lactamase from an Algerian clinical isolate of Salmonella senftenberg. FEMS Microbiol Lett 152:255-260.
23. Kraulis PJ. 1991. MOLSCRIPT: A program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr 24:946-950.
24. Kuzin AP, Liu H, Kelly JA, Knox JR. 1995. Binding of cephalothin and cefotaxime to D-Ala-D-Ala-peptidase reveals a functional basis of a natural mutation in a low-affinity penicillin-binding protein and in extended-spectrum beta-lactamases. Biochemistry 34:9532-9540.
25. Laskowski RA, MacArthur MW, Moss DS, Thornton JM. 1993. PROCHECK: A program to check the stereochemical quality of protein structures. J Appl Crystallogr 26:283-291.
26. Lobkovsky E, Billings EM, Moews PC, Rahil J, Pratt RF, Knox JR. 1994. Crystallographic structure of a phosphonate derivative of the Enterobacter cloacae P99 cephalosporinase: Mechanistic interpretation of a beta-lactamase transition-state analog. Biochemistry 33:6762-6772.
27. Lobkovsky E, Moews PC, Liu H, Zhao H, Frere JM, Knox JR. 1993. Evolution of an enzyme activity: crystallographic structure at 2-A resolution of cephalosporinase from the ampC gene of Enterobacter cloacae P99 and comparison with a class A penicillinase. Proc Natl Acad Sci USA 90:11257-11261.
28. Massova I, Mobashery S. 1998. Kinship and diversification of bacterial penicillin-binding proteins and beta-lactamases. Antimicrobiol Agents Chemother 42:1-17.
29. Morosini MI, Negri MC Shoichet B, Baquero MR, Baquero F, Blazquez J. 1998. An extended-spectrum AmpC-type beta-lactamase obtained by in vitro antibiotic selection. FEMS Microbiol Lett 165:85-90.
30. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M7-A4, Vol. 17. Villanova, Pennsylvania: University of Villanova.
31. Neu HC. 1992. The crisis in antibiotic resistance. Science 257:1064-1073.
32. Nukaga M, Haruta S, Tanimoto K, Kogure K, Taniguchi K, Tamaki M, Sawai T. 1995. Molecular evolution of a class C beta-lactamase extending its substrate specificity. J Biol Chem 270:5729-5735.
33. Oefner C, D'Arcy A, Daly JJ, Gubernator K, Charnas RL, Heinze I, Hubschwerlen C, Winkler FK. 1990. Refined crystal structure of beta-lactamase from Citrobacter freundii indicates a mechanism for beta-lactam hydrolysis. Nature 343:284-288.
34. Otwinowski Z, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 276:307-326.
35. Sanders CC. 1992. Beta-lactamases of Gram-negative bacteria: New challenges for new drugs. Clin Infect Dis 14:1089-1099.
36. Sanders CC, Bradford PA, Ehrhardt AF, Bush K, Young KD, Henderson TA, Sanders WE Jr. 1997. Penicillin-binding proteins and induction of AmpC beta-lactamase. Antimicrobial Agents Chemother 41:2013-2015.
37. Strynadka NC, Adachi H, Jensen SE, Johns K, Sielecki A, Betzel C, Sutoh K, James MN. 1992. Molecular structure of the acyl-enzyme intermediate in beta-lactam hydrolysis at 1.7 A resolution. Nature 359:700-705.
38. Strynadka NC, Martin R, Jensen SE, Gold M, Jones JB. 1996. Structure-based design of a potent transition state analogue for TEM-1 beta-lactamase. Nat Struct Biol 3:688-695.
39. Sutherland R. 1991. Beta-lactamase inhibitors and reversal of antibiotic resistance. Trends Pharmacol Sci 12:227-232.
40. Thornton JM, Singh J, Campbell S, Blundell TL. 1988. Protein-protein recognition via side-chain interactions. Biochem Soc Trans 16:927-930.
41. Usher KC, Blaszczak LC, Weston GS, Shoichet BK, Remington SJ. 1998. Three-dimensional structure of AmpC beta-lactamase from Escherichia coli bound to a transition-state analogue: Possible implications for the oxyanion hypothesis and for inhibitor design. Biochemistry 37:16082-16092.
42. Weston GS, Blazquez J, Baquero F, Shoichet BK. 1998. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-Lactamase. J Med Chem 41:4577-4586.